Tackling Bias in Health
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
African Cancer Database Debuts
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
A Ghanaian Scientist’s Quest to Create a Genetic Map of Cancer in Africa
Sequencing the human genome enables scientists to study human biology in a granular fashion and use that information to create treatments for things like cancer. Yet, of the human genomes studied so far, only 2% have been those of Africans. Yemaachi Biotech company in Ghana is addressing that through its Africa Cancer Atlas, partnering with […]
Yemaachi Biotech, the Ghanaian Company Building the “African Cancer Atlas”
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
‘The Field of Human Ancestry is Rife with Racism’: Pioneering Project to Build Cancer Database in Africa.
When Yaw Bediako lost his father to liver cancer, it set the Ghanaian immunologist on a journey to know more about the disease. He quickly realised the burden of cancer in Africa was much greater than he had thought – accounting for about 700,000 deaths every year – and that very few scientific papers about the disease […]
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership with Roche
Roche has signed as the founding partner to initiate the consortium which will generate genomic and clinical data from up to 7,500 African cancer patients ACCRA, Ghana & WASHINGTON–(BUSINESS WIRE)–Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch The African Cancer Atlas (TACA). This initiative aims […]
Yemaachi and Institut Pasteur Tunis Forge Oncogenetics Partnership to Sequence and Characterise Inflammatory Breast Cancer in Patients of African Descent
Partnership is emblematic of a global effort to characterise cancer development and progression in individuals of African descent, who have traditionally been excluded from genomic oncology studies and clinical trials 22nd October 2024, Tunis, Tunisia — Precision oncology company Yemaachi Biotech and Institut Pasteur Tunis today announced a research partnership investigating genomics in inflammatory breast […]
Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies
David Greenwood, Marianne Shawe-Taylor, Hermaleigh Townsley, Joshua Gahir, Nikita Sahadeo, Yakubu Alhassan, Charlotte Chaloner, Oliver Galgut, Gavin Kelly, David L V Bauer, Emma C Wall, Mary Y Wu, Edward J Carr Bioinformatics Advances, Volume 4, Issue 1, 2024, vbae146, https://doi.org/10.1093/bioadv/vbae146 Abstract Motivation: Observational cohort studies that track vaccine and infection responses offer real-world data to inform pandemic policy. Translating biological hypotheses, such as whether different patterns of […]
Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases
Emmanuella Amoako abc, Setor Amuzu a, Emmanuel Owusu Ofori b, Harry Sefoga Akligoh a, Randy Tackie a, Barikisu Anna Ibrahim a, Emmanuel Kofi Quaye a, Patrick Kafui Akakpo bcd, Luke Adagrah Aniakwo b, Bashiro Jimah bc, Kofi Ulzen-Appiah bc, David Hutchful a, Aida Manu a, Joyce M Ngoi a, Lily Paemka a, Yakubu Alhassan ae, Ernest Amo Obeng d, Nicole Lim f, Lisa Rajah f, Michelle Pek f…Yaw Bediako a Transl Oncol; 49: 102100, 2024 Nov, https://doi.org/10.1016/j.tranon.2024.102100 Abstract Purpose: Breast cancer is a major cause of cancer-related mortality among African women. The adoption of molecular genomic technologies in the management of cancer cases is limited in Africa. To provide much-needed insights on the feasibility and utility […]